256 related articles for article (PubMed ID: 31641947)
1. Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
Buisman FE; Grünhagen DJ; Homs MYV; Grootscholten C; Filipe WF; Kemeny NE; Cercek A; D'Angelica MI; Donswijk ML; van Doorn L; Emmering J; Jarnagin WR; Kingham TP; Klompenhouwer EG; Kok NFM; Kuiper MC; Moelker A; Prevoo W; Versleijen MWJ; Verhoef C; Kuhlmann KFD; Groot Koerkamp B
Ann Surg Oncol; 2019 Dec; 26(13):4599-4607. PubMed ID: 31641947
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: A multicenter, retrospective cohort study.
Muaddi H; D'Angelica M; Wiseman JT; Dillhoff M; Latchana N; Roke R; Ko YJ; Carpizo D; Spencer K; Fields RC; Williams G; Aucejo F; Acevedo-Moreno LA; Billingsley KG; Walker BS; Mayo SC; Karanicolas PJ
J Surg Oncol; 2021 Jan; 123(1):252-260. PubMed ID: 33095919
[TBL] [Abstract][Full Text] [Related]
4. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver.
Martin RC; Edwards MJ; McMasters KM
Am J Surg; 2004 Dec; 188(6):714-21. PubMed ID: 15619489
[TBL] [Abstract][Full Text] [Related]
5. Recurrence After Liver Resection of Colorectal Liver Metastases: Repeat Resection or Ablation Followed by Hepatic Arterial Infusion Pump Chemotherapy.
Buisman FE; Filipe WF; Kemeny NE; Narayan RR; Srouji RM; Balachandran VP; Boerner T; Drebin JA; Jarnagin WR; Kingham TP; Wei AC; Grünhagen DJ; Verhoef C; Koerkamp BG; D'Angelica MI
Ann Surg Oncol; 2021 Feb; 28(2):808-816. PubMed ID: 32648182
[TBL] [Abstract][Full Text] [Related]
6. Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases.
Chakedis J; Beal EW; Sun S; Galo J; Chafitz A; Davidson G; Reardon J; Dillhoff M; Pawlik TM; Abdel-Misih S; Bloomston M; Schmidt CR
J Surg Oncol; 2018 Dec; 118(7):1065-1073. PubMed ID: 30376157
[TBL] [Abstract][Full Text] [Related]
7. Colorectal hepatic metastases: resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival.
Heslin MJ; Medina-Franco H; Parker M; Vickers SM; Aldrete J; Urist MM
Arch Surg; 2001 Mar; 136(3):318-23. PubMed ID: 11231853
[TBL] [Abstract][Full Text] [Related]
8. The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
Buisman FE; Galjart B; van der Stok EP; Kemeny NE; Balachandran VP; Boerner T; Cercek A; Grünhagen DJ; Jarnagin WR; Kingham TP; Verhoef C; Koerkamp BG; D'Angelica MI
HPB (Oxford); 2020 Sep; 22(9):1271-1279. PubMed ID: 31889627
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of radiofrequency ablation of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
Martin RC; Scoggins CR; McMasters KM
J Surg Oncol; 2006 Apr; 93(5):387-93. PubMed ID: 16550574
[TBL] [Abstract][Full Text] [Related]
10. Timing of Primary Tumor Resection in Synchronous Metastatic Colon Cancer Patients Undergoing Hepatic Arterial Infusion Pump Placement.
Verheij FS; Soares KC; Beets GL; Kok NFM; Yuval JB; Kemeny NE; Kingham TP; Jarnagin WR; D'Angelica MI; Garcia-Aguilar J
Ann Surg Oncol; 2022 Mar; 29(3):2044-2051. PubMed ID: 34751873
[TBL] [Abstract][Full Text] [Related]
11. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
[TBL] [Abstract][Full Text] [Related]
12. Recurrence patterns after complex multimodality therapy and hepatic arterial infusion for colorectal liver metastases: A reflection of biology and technique.
Hernandez MC; Fan D; Sandhu J; Mahuron K; Kessler J; Raoof M; Fakih M; Singh G; Fong Y; Melstrom LG
J Surg Oncol; 2024 Jun; 129(7):1254-1264. PubMed ID: 38505908
[TBL] [Abstract][Full Text] [Related]
13. Salvage regional therapy using hepatic artery infusion pump in unresectable chemotherapy resistant colorectal liver metastases.
O'Leary MP; Wang C; Sandhu J; Malhotra GK; Thornblade LW; Lau C; Melstrom LG; Fong Y; Singh G; Fakih MG
Am J Surg; 2022 Jun; 223(6):1151-1156. PubMed ID: 34696847
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Histopathological Growth Patterns of Colorectal Liver Metastases on the Survival Benefit of Adjuvant Hepatic Arterial Infusion Pump Chemotherapy.
Filipe WF; Meyer YM; Buisman FE; van den Braak RRJC; Galjart B; Höppener DJ; Jarnagin WR; Kemeny NE; Kingham TP; Nierop PMH; van der Stok EP; Grünhagen DJ; Vermeulen PB; Groot Koerkamp B; Verhoef C; D'Angelica MI
Ann Surg Oncol; 2023 Dec; 30(13):7996-8005. PubMed ID: 37782413
[TBL] [Abstract][Full Text] [Related]
15. [Cytoreductive surgery with placement of intra-arterial infusion pump for unresectable liver tumors].
Rutkin IO; Granov DA; Polysalov VN; Borovik VV; Generalov MI
Vopr Onkol; 2007; 53(2):206-9. PubMed ID: 17663176
[TBL] [Abstract][Full Text] [Related]
16. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
17. Robotic assisted placement of hepatic artery infusion pump is a safe and feasible approach.
Dhir M; Zenati MS; Padussis JC; Jones HL; Perkins S; Clifford AK; Steve J; Hogg ME; Choudry HA; Holtzman MP; Zeh HJ; Pingpank JF; Bartlett DL; Zureikat AH
J Surg Oncol; 2016 Sep; 114(3):342-7. PubMed ID: 27529576
[TBL] [Abstract][Full Text] [Related]
18. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases.
Rudroff C; Altendorf-Hoffmann A; Stangl R; Scheele J
Langenbecks Arch Surg; 1999 Jun; 384(3):243-9. PubMed ID: 10437612
[TBL] [Abstract][Full Text] [Related]
19. Use of Hepatic Artery Infusion Pumps in the Treatment of Hepatic Metastases.
Parks L; De Villiers AA
Clin J Oncol Nurs; 2022 Nov; 26(6):602-605. PubMed ID: 36413718
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases.
Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P
Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
